Kim Theilgaard-Mønch

Kim Theilgaard-Mønch

Clinical Associate Professor, Group leader

Member of:

    ORCID: 0000-0002-4239-4939

    Publication year:
    All
    1 - 2 out of 2Page size: 10
    1. 2019
    2. Published

      Identification of two distinct pathways of human myelopoiesis

      Drissen, R., Thongjuea, S., Theilgaard-Mønch, Kim & Nerlov, C., 2019, In: Science immunology. 4, 35, eaau7148.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML

      Jakobsen, J. S., Laursen, L. G., Schuster, Mikkel Bruhn, Pundhir, Sachin, Schoof, E., Ge, Y., d'Altri, T., Vitting-Seerup, K., Rapin, N., Gentil, C., Jendholm, J., Theilgaard-Mønch, Kim, Reckzeh, K., Bullinger, L., Döhner, K., Hokland, P., Fitzgibbon, J. & Porse, Bo Torben, 2019, In: Science Advances. 5, 7, p. 1-16 16 p., eaaw4304.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 3997971